Virtual Reality for Reducing Sedation During Breast Surgery
(V-RAPS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether virtual reality (VR Therapy) can reduce the need for sedatives during breast surgery. Using a virtual reality headset, patients might require less propofol, a common sedative, while awake during the procedure. Participants will be divided into two groups: one using virtual reality and the other receiving standard care. This trial suits women undergoing elective breast surgery with a specific type of anesthesia and without conditions such as hearing or visual impairments, seizures, or recent eye or facial surgeries. As an unphased trial, this study offers patients a unique opportunity to explore innovative approaches to surgery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this virtual reality device is safe for reducing sedation during breast surgery?
Research shows that virtual reality (VR) is generally safe and easy to use. Studies have found that VR can reduce anxiety and the need for extra medication in surgical patients. In these studies, patients did not report any serious side effects from using VR.
Some individuals might experience mild discomfort, such as dizziness or nausea, but these effects are usually temporary and resolve on their own. Since VR is not a drug, it avoids risks associated with medications, like allergic reactions or interactions with other drugs.
Overall, evidence suggests that VR is a safe option for reducing the need for extra medication during surgery.12345Why are researchers excited about this trial?
Researchers are excited about using virtual reality during breast surgery because it offers a non-drug alternative to reduce sedation. Typically, patients rely on medications to stay calm and pain-free during surgery, which can have side effects. Virtual reality distracts patients by immersing them in a different environment, potentially lowering the need for heavy sedation. This approach could lead to faster recovery times and fewer medication-related complications, making the surgical experience safer and more comfortable.
What evidence suggests that virtual reality is effective for reducing sedation during breast surgery?
Research has shown that virtual reality (VR), which participants in this trial may use, can reduce the need for sedation in surgical patients. For example, one study found that patients using VR during breast surgery required less IV sedation. This suggests that VR might help patients feel more relaxed, reducing the need for calming drugs. By decreasing sedation requirements, VR could also speed up recovery after surgery. Overall, these findings suggest that VR has the potential to make surgery less stressful and more comfortable.12345
Who Is on the Research Team?
Pascal Laferriere-Langlois, MD, MSc
Principal Investigator
Ciusss de L'Est de l'Île de Montréal
Are You a Good Fit for This Trial?
This trial is for adult female patients planning to have elective breast surgery under regional anesthesia. Participants should not have any conditions that exclude them from the study, which are not specified here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo breast surgery with either standard care or virtual reality intervention to assess propofol requirements
Post-Anesthesia Care
Participants are monitored in the Post-Anesthesia Care Unit (PACU) for recovery and adverse events
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of secondary outcomes like patient satisfaction and adverse events
What Are the Treatments Tested in This Trial?
Interventions
- Virtual Reality
Virtual Reality is already approved in United States for the following indications:
- Functional Dyspepsia
- Irritable Bowel Syndrome (IBS)
- Gastroparesis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ciusss de L'Est de l'Île de Montréal
Lead Sponsor
Paperplane Therapeutics
Collaborator